Sarilumab

Brand name: Kevzara

Rank #339 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$30.5M

Total Cost

Share:

6,822

Total Claims

$30.5M

Total Cost

331

Prescribers

$4,466

Cost per Claim

149

Beneficiaries

7,093

30-Day Fills

$92K

Avg Cost/Provider

21

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$30.5M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $30.5M total

🔎 Data Overview

💰

At $4,466 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $204,495 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Sarilumab

#ProviderSpecialtyLocationClaimsCost
1Jorge MundoRheumatologyHumacao, PR157$635K
2Jyothi MallepalliRheumatologyMonroe, LA96$412K
3Robert HolmesRheumatologyPollocksville, NC92$404K
4Maria VintimillaRheumatologyNew Smyrna Beach, FL83$393K
5Eugene KissinRheumatologyBoston, MA80$339K
6Edgar MartorellInternal MedicineOrlando, FL55$278K
7Alvin WellsRheumatologyDestin, FL52$255K
8Lucia HardiRheumatologyLexington, KY55$252K
9Noemi Varela-RosarioInternal MedicineAguada, PR58$240K
10Maria WatsonRheumatologyHope Mills, NC55$233K
11Angela PhamRheumatologyCarrollton, GA54$231K
12Syed RazaRheumatologyMemphis, TN56$228K
13Dharmarajan RamaswamyInternal MedicineHemet, CA53$218K
14Linh McclureNurse PractitionerOrlando, FL49$215K
15William SullivanRheumatologyFairhope, AL51$211K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
336Diphth,pertuss(Acell),tet Vac (Boostrix Tdap)$31.2M466,555
337Tafamidis Meglumine (Vyndaqel)$31.0M1,387
338Midodrine Hcl (Midodrine Hcl)$30.9M383,390
339Sarilumab (Kevzara)$30.5M6,822
340Dabrafenib Mesylate (Tafinlar)$30.4M2,377
341Testosterone (Testosterone)$30.4M131,549
342Hydroxyzine Hcl (Hydroxyzine Hcl)$30.2M1,474,936

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology